Q&A_2
Published: 06/06/2013
Description
FDA-SOL-13-1116651 – Access to Data & Analytics on Expenditure/Activity by Pharmaceutical Companies on Prescription Drug Promotion Responses to Questions 2 What number of Disclosure Clearances for Aggregated Data outside the Agency should the Offer...
